• Beijing and Brussels are entering negotiations to resolve disputes related to electric vehicles.
  • Prosus reported an 84% jump in full-year core net profit.
  • ArgenX shares rose by 8% this morning after announcing FDA approval of Vyvgart Hytrulo for chronic inflammatory demyelinating polyneuropathy on Friday, with the stock price returning to EUR 400.
  • THG has decided to divest its portfolio of luxury goods websites to Frasers Group, owned by Mike Ashley.
  • Merger discussions are ongoing between Julius Bär and EFG International.
  • ABN Amro is reportedly interested in purchasing HSBC's German wealth management unit.
  • Prudential Plc has announced a plan to buy back $2 billion of its shares.
  • A study has found that Novo Nordisk's Wegovy leads to more significant weight loss in women than in men with the same heart disease.
  • Engine Capital has taken a stake in C&C Group, according to Bloomberg.
  • Hugo Boss is looking to increase its production within Europe.
  • Holcim has acquired a Swiss family-owned recycling business.
  • Identiv has started multiple legal proceedings against Tageos.
  • The FDA has approved Roche's drug Piasky.
  • Deutz, an engine manufacturer, is planning to venture into the defense sector.
  • BioSenic has engaged in dilutive At-The-Market (ATM) financing.
  • Apple will delay the launch of new AI features in Europe due to regulatory concerns, and separately, it is rumored to be discussing an AI partnership with Meta Platforms.
  • United Parcel Service (UPS) has agreed to sell its Coyote Logistics unit to RXO for $1 billion.
  • Eli Lilly's weight-loss drug Zepbound has been shown to treat sleep apnea in 52% of patients.
  • ByteDance is working with Broadcom on developing an advanced AI chip, as reported by Reuters.
  • The U.S. Justice Department has not decided whether to pursue a lawsuit against Boeing.
  • Qualcomm shares have dropped following rumors that a Snapdragon-powered laptop is incompatible with certain software.
  • Capital One and Walmart have reached a settlement over their credit card partnership dispute.
  • KKR has acquired the European live performance company Superstruct.
  • NeuroSense Therapeutics has been notified of its pending delisting from Nasdaq.
  • Singular Genomics Systems is proceeding with a 1-for-30 reverse stock split.
  • Nissan is cutting its production capacity in China.
  • Meta Platforms has been in talks with Apple to integrate its generative AI model into Apple's AI systems.
  • The EU has accused Apple's App Store of violating European rules, with potential further action indicated by EU Commissioner Thierry Breton.
  • Eli Lilly's Zepbound has been successful in treating obstructive sleep apnea in trials, causing a nearly 12% drop in RESMED's stock before market opening.
  • Nvidia has entered into an agreement to deploy AI technology in Ooredoo's data centers across five Middle Eastern countries.
  • Broadcom's stock rose by 1.6% before the market opened on news of its collaboration with ByteDance on an AI processor.
  • A Boeing 777 operated by KLM returned to Amsterdam due to a technical problem, causing a 1% drop in Boeing's pre-market shares.
  • UPS's sale of Coyote Logistics to RXO has been finalized for $1.025 billion, with RXO's shares jumping 9.5% before the market opened.
  • Alaska Airlines' flight attendants' union has reached a tentative deal with the airline.
  • Under Armour has agreed to a $434 million settlement over allegations of financial manipulation.